Status:
COMPLETED
Predictive Pre and Peroperative Factors for MODS-2 in Pediatric Cardiac Surgery
Lead Sponsor:
Brugmann University Hospital
Conditions:
Congenital Heart Disease in Children
Cardiac Surgical Procedures
Eligibility:
All Genders
Up to 16 years
Brief Summary
Pediatric cardiac surgery has a relatively high morbi-mortality. Despite great advances in surgical techniques, today the mortality rate is about 3% and morbidity is about 30-40%. Outcome has been rel...
Detailed Description
Detailed statistical analysis: 5 multiple imputations via the mice R package will be performed, which is the most appropriate method for a risk model. We then take the mean of the imputed datasets in...
Eligibility Criteria
Inclusion
- patients undergoing pediatric cardiac surgery with cardiopulmonary bypass between 2008 and 2018 at our institution
- accepting blood transfusions
- ASA score 1-4
Exclusion
- Jehova's witness
- ASA 5 status
Key Trial Info
Start Date :
March 18 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 8 2022
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT05284500
Start Date
March 18 2022
End Date
July 8 2022
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Universitaire des Enfants Reine Fabiola
Brussels, Belgium, 1020